Center for Genomic Interpretation

EIN: 820918164 501(c)(3) Education

Sandy, UT

Total Revenue
$266,921
Total Expenses
$337,687
Total Assets
$367,901
Net Assets
$-130,477
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2017
Legal Domicile
UT
Principal Officer
Julie M Eggington
Phone
8018104097
Tax Period
2022-01-01 to 2022-12-31

Center for Genomic Interpretation, founded in 2017, is a small nonprofit in the Education sector that reported $267K in total revenue in fiscal year 2022. Revenue decreased 6% compared to the prior year. Expenses of $338K exceeded revenue, resulting in a 27% operating deficit.

Mission

The mission of the Organization is to build an expertly curated, comprehensive human genetic variant database that, once established, will significantly contribute to the scientific research findings that will be published and made available to the public. Through our work we will identify genetic markers of disease, which is the first step to identifying cures for both hereditary and somatic diseases.

Program Service Accomplishments

Program 1
Expenses: $303,277 Revenue: $89,690

The Organization shall, through interactions and outreach with patients, clinicians, genetics laboratories, genetics advocacy groups, academic institutions, and the general public, advance the...

Read more

The Organization shall, through interactions and outreach with patients, clinicians, genetics laboratories, genetics advocacy groups, academic institutions, and the general public, advance the science and application of genetic variant classification and educate the public on the current scientific status of clinical genetics and the need for improvement in the methods by which clinical genetic diagnoses are determined. Our interaction with the general public through our citizen science efforts, will educate the general population on the science of genetics and genetic variant classification, and will provide a novel and disruptive mechanism toward the classification of genetic variants. Specific activities that will accomplish these ends are the deposit of clinical genetic variant classifications into publicly funded and publicly available database repositories, the transparent publication of variant classification methods and conclusions in peer-reviewed scientific journals, and the involvement of crowdsourcing efforts, all of which will educate the general public and the academic community and increase the awareness of the need for increased quality in clinical genetics.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $176,916
Program Service Revenue $89,690
Investment Income $315
Other Revenue $0
TOTAL REVENUE $266,921

Expense Breakdown

Grants Paid $0
Salaries & Benefits $230,206
Fundraising Expenses $0
Program Expenses $303,277
Other Expenses $107,481
TOTAL EXPENSES $337,687

Year-over-Year Comparison

2022 2021 Change
Revenue $266,921 $284,425 -0.1%
Expenses $337,687 $324,248 +0.0%
Net Income $-70,766 $-39,823 +0.8%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
3
Employees
4
Volunteers
N/A

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
1
$31,200
Total Directors
0
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Julie M Eggington CEO 50.00
Officer
$31,200 $0 $31,200
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2022 $266,921 $337,687 $367,901 $-70,766
2021 $284,425 $324,248 $441,519 $-39,823
2019 $273,713 $260,847 $82,211 $12,866
2018 $205,337 $144,293 $69,413 $61,044
Explore More Nonprofits
Top 100 Nonprofits in Utah Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare Center for Genomic Interpretation with other nonprofits in Utah and across the country.